K2 Principal Fund L.P. bought a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 195,292 shares of the company's stock, valued at approximately $1,945,000. K2 Principal Fund L.P. owned approximately 0.87% of Oaktree Acquisition Corp. III Life Sciences at the end of the most recent reporting period.
Separately, Shaolin Capital Management LLC purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at approximately $5,478,000.
Oaktree Acquisition Corp. III Life Sciences Trading Up 0.6%
NASDAQ OACC traded up $0.06 on Wednesday, reaching $10.47. The company had a trading volume of 96,964 shares, compared to its average volume of 98,282. The business has a fifty day moving average price of $10.21. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.95 and a 52-week high of $10.85.
Oaktree Acquisition Corp. III Life Sciences Profile
(
Free Report)
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
Read More
Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.
While Oaktree Acquisition Corp. III Life Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
